(Q46002795)

18 December 2017

title

Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals. (English)

1 reference

18 December 2017

main subject

United States of America

0 references

1 reference

Ryan P Merkow

1

1 reference

18 December 2017

Karl Y Bilimoria

2

1 reference

18 December 2017

Martin D McCarter

3

1 reference

18 December 2017

Warren B Chow

4

1 reference

18 December 2017

Clifford Y Ko

5

1 reference

18 December 2017

David J Bentrem

6

1 reference

18 December 2017

publication date

20 July 2011

1 reference

18 December 2017

Annals of Surgical Oncology

published in

1 reference

18 December 2017

volume

19

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

357-364

1 reference

18 December 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Worldwide esophageal cancer collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Trends in the management of esophageal carcinoma based on provider volume: treatment practices of 618 esophageal surgeons

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

Referral Patterns, Treatment Choices, and Outcomes in Locoregional Esophageal Cancer: A Population-Based Analysis of Elderly Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-1945-3

10.1245/S10434-011-1945-3

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1009149598

0 references

Fatcat ID

release_mkqaltjeojdkpl7ygw3djo2eu4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mkqaltjeojdkpl7ygw3djo2eu4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

18 December 2017